The cervicovaginal microbiome's role in Chlamydia infections underscores the need for molecular classification to enhance ...

Women who develop bacterial vaginosis (BV) often later acquire chlamydia, a common and potentially serious sexually ...

Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical ...

Metro Detroit has earned the dubious distinction of leading the country with the highest rate of sexually transmitted ...

HIV, the incurable virus that can lead to AIDS if not treated, is most prevalent in Georgia, with 23.1 cases per 100,000 ...

The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based ...

The analyses were performed before infection with chlamydia, at the time of infection, and following antibiotic treatment, allowing the researchers to identify which combination of cervicovaginal ...

Understanding ovarian cancer's early warning signs has long challenged medical professionals, making risk factor awareness ...

More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old ...

US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...

Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs).